B-TEMIA Doubles its Commercialization and Manufacturing Capacities
Québec City, QC | October 25, 2016 – B-TEMIA Inc., the developer and manufacturer of the Dermoskeleton™ mobility assistive technology announces that it has recently opened its new head office in St-Augustin, Québec City. The new facility will enable the Company to double its commercialization and manufacturing capacities.
“In 2016, we decisively transitioned the Company towards the full commercialization of our Keeogo™ walking assistive device in Canada, while advancing the groundwork for its future introduction in the US market. It became clear that in order to service our customers more effectively and maintain our growth, we needed to move to a new location,“ said Stéphane Bédard, Founder and CEO of B-TEMIA. “Regrouping all our operations into one larger working space will significantly increase our capability to mature our industrial phase, improve our operational performance as well as upgrade our employees’ working environment ,” added Mr. Bedard.
B-TEMIA has now put in place all the necessary resources to accelerate its commercialization efforts and make its exclusive Keeogo™ device available throughout Canada. With over 20 employees, the Company has recently added key operational skills in sales, customer service, regulatory and clinical management to support its growth in the Canadian market and the completion of the US Food and Drug Administration (FDA) clearance process.
Keeogo™ is a powered assistive walking device and is the first product incorporating the Dermoskeleton™ technology developed by B-TEMIA. Keeogo™ has been used by individuals with medical conditions such as osteoarthritis of the knee, multiple sclerosis, Parkinson’s disease, stroke, incomplete SCI and other conditions that impact mobility. Keeogo™ is commercially available for purchase or rental in Canada. It is not yet available in the United States. The device is currently undergoing a pivotal clinical trial in both Canada and the United States.
Founded in 2010, B-TEMIA Inc. is a medical device manufacturer that develops and markets cutting-edge products in the growing market of human augmentation systems. B-TEMIA operates through two wholly-owned subsidiaries, B-TEMIA Inc. and B‑TEMIA USA Inc., in the medical, industrial and military fields. B-TEMIA owns a patented technology called Dermoskeleton™ that restores, maintains or enhances the mobility of users.
Jean-Pierre Trudel and Associates
Phone: (514) 347-6111